Skip to Content

Posaconazole Oral Suspension

Last Updated: August 11, 2015
Status: Resolved

Products Affected - Description

Posaconazole oral suspension

Reason for the Shortage

  • Merck states the shortage was due to manufacturing delays.
  • Noxafil delayed-release tablets and intravenous injections are not affected by this shortage.
  • Merck is the only supplier of posaconazole oral suspension.

Available Products

Noxafil oral suspension, Merck
40 mg/mL, 105 mL glass bottle, 1 count (NDC 00085-1328-01)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

August 11, June 8, April 20, March 2, January 28, 2015; December 22, 2014; November 26, 2014; November 6, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide